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The EGF Receptor Provides an Essential
Survival Signal for SOS-Dependent
Skin Tumor Development
Epidermal growth factor receptor (EGFR) activation is
a central event in the regulation of epidermal develop-
ment. The EGFR is activated by several ligands such
as epidermal growth factor (EGF), transforming growth
factor a (TGFa), amphiregulin, heparin binding EGF (HB-
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EGF), b-cellulin, and epiregulin (Prigent and Lemoine,*Research Institute of Molecular Pathology (IMP)
1992; Earp et al., 1995). Ligand binding to the EGFRA-1030 Vienna
induces receptor dimerization and activation of the in-Austria
trinsic tyrosine kinase with subsequent autophosphory-² Imperial Cancer Research Fund
lation of key tyrosines located at the carboxyl terminal
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tail of the receptor (Prigent and Lemoine, 1992; Lemmon
United Kingdom and Schlessinger, 1994; Earp et al., 1995). Phosphory-
³Department of Pharmacology lated tyrosine residues act as binding sites for proteins
New York Universtiy Medical Center containing Src-homology 2 domains (SH2) such as Grb2,
New York, New York 10016 SHC, and PLCg, which, in turn, activate complex down-
stream signaling cascades, thus transducing extracellu-
lar stimuli to the nucleus (Lemmon and Schlessinger,
1994; Weiss et al., 1997). The adaptor protein Grb2Summary
seems to be critically involved in coupling signals from
receptor tyrosine kinases to Ras through its associationThe EGF receptor (EGFR) is required for skin develop-
with Son of sevenless (SOS), a guanine nucleotide ex-ment and is implicated in epithelial tumor formation.
change factor that catalyzes the activation of Ras pro-Transgenic mice expressing a dominant form of Son
teins by facilitating GDP±GTP exchange (Schlessinger,of Sevenless (SOS-F) in basal keratinocytes develop
1994; Weiss et al., 1997). Stimulation of cells with growthskin papillomas with 100% penetrance. However, tu-
factors leads to the association of SOS±Grb2 complexes
mor formation is inhibited in a hypomorphic (wa2) and with activated receptors, and this is proposed to stimu-
null EGFR background. Similarly, EGFR-deficient fi- late Ras through the juxtaposition of SOS and Ras at
broblasts are resistant to transformation by SOS-F the membrane (Schlessinger, 1994; Weiss et al., 1997).
and rasV12, however, tumorigenicity is restored by Constitutive active SOS proteins can be obtained by
expression of the anti-apoptotic bcl-2 gene. The K5- targeting variants of SOS to the membrane via the addi-
SOS-F papillomas and primary keratinocytes from wa2 tion of farnesylation signals (Aronheim et al., 1994).
mice display increased apoptosis, reduced Akt phos- Moreover, deletion of the carboxyl terminal tail of SOS
phorylation and grafting experiments imply a cell- containing the Grb2 binding site also activates the SOS
autonomous requirement for EGFR in keratinocytes. protein (Wang et al., 1995). These dominant forms of
Therefore, EGFR functions as a survival factor in onco- SOS have been shown to transform NIH3T3 fibroblasts
in vitro and to constitutively activate the Ras/ERK path-genic transformation and provides a valuable target
way (Aronheim et al., 1994; Wang et al., 1995).for therapeutic intervention in a broader range of tu-
Numerous studies have documented alterations inmors than anticipated.
growth factor signaling pathways in the development of
human epithelial neoplasms (Derynck, 1992; Reich-Introduction
mann, 1994). Amplifications, rearrangements, and over-
expression of the EGFR have been shown to occur at
The epidermis is a stratified squamous epithelium com- high frequency in human squamous cell carcinomas and
posed mainly of keratinocytes, whose proliferation and glioblastomas (Libermann et al., 1985; Derynck, 1992)
differentiation must be tightly regulated and coordinated and activating mutations of the ras gene are observed
(Fuchs, 1990, 1992). Basal keratinocytes, which are in a variety of human neoplasms (Barbacid, 1990). Intro-
attached to the basement membrane, are undifferenti- duction of viral Ras into mouse epidermal cells in vivo
ated and have proliferative potential. Before entering and in vitro can initiate skin tumors (Brown et al., 1986;
the differentiation program, they withdraw from the cell Roop et al., 1986) and expression of an activated form
cycle and migrate toward the surface of the epidermis, of Ha-Ras in the suprabasal layer of the epidermis of
leading to the formation of the outermost layer of the transgenic mice induces the development of benign
epidermis composed of anucleated dead squames, papillomas at sites of promotional stimuli (Bailleul et al.,
which are continuously shed from the surface of the
1990). Similarly, transgenic mice expressing the EGFR
skin (Jones and Watt, 1993).
ligand TGFa in basal or suprabasal keratinocytes display
thickening of the epidermis and develop papillomas
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June 7, 2000. EGFR signaling is also of physiological relevance dur-
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ing normal epithelial development. Some of the EGFR the highest levels of expression of the SOS-F protein
in the skin (Figure 1B and data not shown). The latterligands are synthesized by normal keratinocytes both
in vitro and in vivo (Vardy et al., 1995). The EGFR is most displayed dramatic skin hyperplasias on the entire body
(Figure 1D), open eyes (Figure 1D), runted limbs (Figurestrongly expressed in the basal layer of the epidermis
and in the outer root sheath of hair follicles, in which 1E) and died soon after birth probably due to the inability
to breathe caused by a dramatic thickening of thethe proliferating keratinocytes reside (King et al., 1990;
Sibilia and Wagner, 1995). The number of receptors de- tongue epithelium (data not shown). Founder 893A-1
carrying 3±5 copies of the transgene displayed no ab-creases as keratinocytes migrate to the suprabasal lay-
ers of the epidermis, entering the pathway of terminal normalities at birth, but started to develop severe skin
papillomas after 3 weeks and had to be sacrificed (datadifferentiation (King et al., 1990). Recently, it was shown
that EGFR signaling regulates keratinocyte survival, not shown). Founder 892A-6* carried only one or two
copies of the transgene and showed low expressionsince antibody-mediated inhibition of the EGFR renders
keratinocytes detached from the extracellular matrix levels of the SOS-F protein similar to the endogenous
SOS protein (Figure 1B). Moreover, the SOS-F proteinsusceptible to apoptosis (Rodeck et al., 1997a).
Mice deficient for the TGFa gene develop a wavy coat was expressed in the stomach, thymus, and unaffected
skin and papillomas, but was undetectable in other or-and curly whiskers (Luetteke et al., 1993; Mann et al.,
1993). A similar phenotype is observed in the naturally gans (data not shown). Founder 892A-6*, which was
used to establish the transgenic line, started to developoccurring mouse mutant strain waved-2 (wa2), which is
homozygous for a hypomorphic EGFR allele. Wa2 mice papillomas after two weeks of age (Figure 1F). All trans-
genic offspring developed severe skin alterations on thecarry a point mutation in the kinase domain of the EGFR
resulting in reduced kinase activity (Luetteke et al., 1994; body and tail and histological examination revealed a
hyperplastic epidermis displaying more than the usualFowler et al., 1995). In contrast, mice harboring a null
mutation in the EGFR gene exhibit strain-dependent 3 to 4 suprabasal cell layers present in controls (data not
shown). Within the next 2±3 weeks, these hyperplasticphenotypes with defects in neural and epithelial tissues
and die before weaning age (Miettinen et al., 1995; Sibilia lesions developed into macroscopically visible papillo-
matous structures with no or only very few hair folliclesand Wagner, 1995; Threadgill et al., 1995; Sibilia et al.,
1998). These mutants show impaired epidermal as well present in the affected areas (Figures 1F, 1G, and 4A).
RNA in situ hybridization using a transgene-specificas hair follicle differentiation and fail to develop a hairy
coat, most likely because EGFR signaling is necessary probe revealed expression of K5-SOS-F in all layers
of hyperplastic skins and papillomas. Keratin 14 (K14),for maintenance of hair follicle integrity (Miettinen et al.,
1995; Sibilia and Wagner, 1995; Threadgill et al., 1995; which is normally coexpressed with K5 in the basal layer,
was also detectable throughout the epidermis of theHansen et al., 1997). Similar skin and hair phenotypes
are observed in transgenic mice expressing a dominant hyperplastic lesions and papillomas (data not shown).
These results show that expression of the transgenenegative EGFR (CD533) in the basal layer of the epider-
mis and outer root sheath of the hair follicles (Murillas in the skin results in a hyperproliferative skin disease
leading to hyperplasia and papilloma formation charac-et al., 1995). These results suggest that TGFa/EGFR
signaling plays an essential role in epithelial cell prolifer- terized by an expanded basal compartment.
ation and/or differentiation and is critical for the develop-
ment of normal hair follicles and skin. However, it is Tumor Development Is Impaired in a Hypomorphic
unclear which signaling pathways downstream of the EGFRwa2/wa2 Background
EGFR specifically control these processes. To explore a possible genetic interaction between SOS
To investigate EGFR responsive pathways in the skin, and EGFR, the K5-SOS-F transgene was bred into an
we have generated transgenic mice expressing a domi- EGFR null (2/2) or hypomorphic (wa2/wa2) back-
nant form of hSOS (SOS-F) under the control of a full- ground. Interestingly, skin tumor development was at-
length K5 promoter, which is active in EGFR-expressing tenuated in EGFR2/2K5-SOS-F mice. The transgene
cells. Here, we show that all K5-SOS-F mice develop partially rescued the hair growth defects in the few mu-
spontaneous skin tumors and that tumor development tants obtained and prolonged the lifespan up to 6
is impaired in the absence of EGFR function, likely due months (M. S. and E. F. W., unpublished data). In con-
to increased apoptosis, thereby demonstrating that the trast, in a wa2/wa2 or wa2/2 background, K5-SOS-F
EGFR functions as a survival factor in oncogenic trans- expression did not rescue the curly hair phenotype, sug-
formation. gesting either that SOS controls hair growth but not hair
follicle orientation or that the levels of expression of K5-
Results SOS-F are not appropriate to rescue this phenotype.
Skin tumor development was also severely impaired
in a wa2/wa2 or wa2/2 transgenic background (FigureK5-SOS-F Transgenic Mice Exhibit Skin Hyperplasia
and Develop Papillomas 2A). After 6 months, 85% of wa2/wa2 or wa2/2 K5-
SOS-F mice were still tumor-free, whereas 100% ofThe full-length regulatory region of the K5 gene was
used to express an activated form of human Son of 1/1, 1/2 or wa2/1 K5-SOS-F mice had developed spon-
taneous tumors within the first two months (Figure 2A).Sevenless (SOS-F) in the basal cell compartment of
stratified epithelia and in the outer root sheath of the The average tumor volume was dramatically different
between the groups. Whereas more than 90% of thehair follicles (Aronheim et al., 1994; RamiÂrez et al., 1994)
(Figure 1A). Four transgenic founder mice (892A-6*, papillomas in an EGFR wild-type background were big-
ger than 1 cm3 after 3 weeks of age, tumor volume was893A-1, 893B-1, and 893B-2) were obtained and SOS-F
expression was found to be copy number dependent drastically reduced in the presence of mutant EGFR
alleles (Figure 2B). In addition, the few lesions whichsince the founders harboring 3±5 (893A-1) or more than
50 copies of the transgene (893B-1 and 893B-2) showed developed in a mutant EGFR background only started
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Figure 1. K5-SOS-F Transgenic Mice Exhibit Skin Hyperplasia and Develop Papillomas
(A) Schematic representation of the K5-SOS-F transgene construct. The upper line shows the structure of the wild-type human SOS (hSOS)
cDNA with the position of the catalytic pocket denoted by the Cdc 25 homology domain and the proline-rich region binding the SH3 region
of Grb2. The activated hSOS expressed from the keratin 5 promoter harbors an HA tag at the N terminus, lacks the C-terminal region containing
the Grb2 binding site, and carries the c-Ha-ras farnesilation site (F) instead. B, Bam HI.
(B) Western blot analysis of transgenic skins. Protein extracts from control skin and tumor biopsies of the two surviving founders, 892A-6*
and 893A-1, were immunoblotted with either anti-HA (aHA) or anti-SOS (aSOS1) antibodies as indicated. The positions of the 170 kDa
endogenous mSOS1 and the 155 kDa transgenic SOS-F are indicated.
(C±D) Phenotype of K5-SOS-F transgenic founders and offspring. (C) Normal and (D) transgenic littermate founder 893B-1 at birth. Note open
eyes (big arrow), abnormal limbs (little arrows), and abnormal skin wrinkling and thickening in the transgenic pup, which died shortly after
birth.
(E) Runted limbs and kinky tail of the transgenic pup shown in (D) compared to the control littermate. Founder 893B-2 had very similar
phenotypes and also died soon after birth (not shown).
(F) Adult founder transgenic mouse 892A-6* showing multiple papillomas at different body sites.
(G) Examples of 12-day-old offspring from founder shown in (F) exhibiting extensive and localized areas of abnormal epidermis on the body
and tail compared to two control littermates.
to develop after an extended latency period (more than whereas wild-type cells expressing SOS-F efficiently
formed tumors in nude mice (Figure 3A). In contrast,four months of age) and were frequently localized at the
edges of ear-tag or tail-biopsy sites, suggesting that fibroblasts lacking the EGFR failed to be transformed
by SOS-F, indicating that EGFR signaling is required forthey were induced by wounding.
oncogenic transformation by SOS-F (Figure 3A). Inter-
estingly, expression of bcl-2 restored tumor formationEGFR-Dependent Transformation of Immortalized
of 2/2 fibroblasts expressing SOS-F, suggesting thatFibroblasts by Oncogenic SOS and Ras
the EGFR provides an antiapoptotic signal (Figure 3A).To gain insight into the molecular mechanism of EGFR-
To exclude the possibility that the resistance of 2/2dependent transformation and to examine whether
fibroblasts to SOS-F transformation was due to second-EGFR signaling was a prerequisite for oncogenic trans-
ary genetic modifications, an independent fibroblastformation by components of the Ras signaling pathway
cell line expressing endogenous EGFR was analyzed.in other cell types, immortalized 3T3 fibroblasts isolated
NIH3T3 fibroblasts were first infected with a retrovirusfrom EGFR2/2 fetuses were employed. Their prolifera-
expressing a dominant-negative EGFR mutant (CD533),tion potential compared to wild type was not affected
and then transfected with plasmids encoding SOS-F or(data not shown). Both 2/2 and 1/1 immortalized fibro-
blasts infected with a control virus were not tumorigenic, rasV12 (Figure 3B). Both SOS-F and RasV12 efficiently
Cell
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Figure 2. Tumor Development Is Impaired in a Hypomorphic
EGFRwa2/wa2 Background Figure 3. EGFR-Dependent Transformation of Immortalized Fibro-
Tumor incidence (A) and volume (B) of K5-SOS-F mice in the pres- blasts by Oncogenic SOS and Ras
ence of different EGFR alleles. One hundred percent of EGFR1/1, (A) Tumor formation in nude mice by EGFR1/1 and 2/2 mouse
1/2, and wa2/1 mice carrying the K5-SOS-F transgene develop embryonic fibroblast cell lines infected or transfected with various
large skin papillomas (B, black bars) within 2 months of age (A, constructs. Fibroblasts were infected with a retrovirus encoding
black circles), whereas 50% of EGFR wa2/wa2 and wa2/2 remain SOS-F or an empty virus. Successively, 2/2 SOS-F fibroblasts were
tumor free for more than 12 months (A, gray squares) and never transfected with bcl-2. Tumorigenicity was assayed after subcuta-
exceed the volume of 1 cm3 (B, gray bars). Only skin lesions $ 0.02 neous injection of 1 3 106 cells into nude mice. There was no differ-
cm3 (marked by asterisks) were scored as tumors in (A). 1/1, 1/2, ence in the infection and transfection frequency between wild-type
wa2/1, and wa2/wa2, wa2/2 K5-SOS-F mice, respectively, were and 2/2 cells.
grouped since they showed similar tumor incidences and volumes. (B) Transforming activity of NIH 3T3 cells first stably infected with
an empty (N2) retrovirus or with a retrovirus harboring a dominant
negative EGFR (CD533) and successively with an empty plasmid
(mock) or constructs encoding SOS-F or rasV12. Transformationtransformed NIH3T3 cells as judged by focus formation
was measured by focus assay or by the ability to form tumors inin vitro and tumor formation in nude mice (Figure 3B).
nude mice.Inhibition of EGFR function by expression of CD533
(C) Increased apoptosis in SOS-F or rasV12 transformed NIH 3T3completely abolished transformation by SOS-F (Figure
cells in the presence of a dominant-negative EGFR (CD533) as mea-
3B). Moreover, CD533 expression almost completely sured by flow-cytometry after annexinV-FITC/propidium iodide (PI)
abolished transformation by RasV12, suggesting that staining. The bar diagram shows the percetage of apoptotic cells
EGFR is not only required for oncogenic transformation as the sum of annexinV single and annexinV/PI double positive cells.
by SOS-F, but also for transformation by other compo- Results of one experiment are shown and the data represent the
mean 6 SD of the analysis of three independent cultures of thenents of the Ras signaling pathway (Figure 3B).
respective genotypes. A second independent experiment gave veryWhen apoptosis was measured in these transfected
similar results (data not shown). Similar differences in apoptosisfibroblasts, no difference in the percentage of apoptotic
among the various cell lines were observed when fibroblasts werecells was detectable between controls and cells ex-
grown in 10% serum (data not shown). NIH 3T3 fibroblasts infectedpressing a dominant-negative EGFR (Figure 3C). Strik-
with a retrovirus expressing the wild-type human EGFR (EGFR) were
ingly, in SOS-F- or rasV12-transfected NIH3T3 fibro- taken as control. The expression of the respective transfected or
blasts, inhibition of EGFR function by CD533 resulted infected proteins was verified by Western blot analysis (data not
in a marked increase in the number of apoptotic cells shown).
(Figure 3C). These results suggest that EGFR plays an
important role in antiapoptotic signaling in oncogenic
transformation by components of the Ras signaling
pathway.
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Figure 4. Increased Apoptosis and Impaired
Differentiation in EGFRwa2/- K5-SOS-F Pap-
illomas and Primary Keratinocytes
(A±D) Anti-Ki67 immunostaining of papillo-
mas isolated from a 3-week-old 1/1 (A and
C) and a 10-month-old wa2/2 (B and D) trans-
genic mouse. The number of proliferating
cells which have extended to the suprabasal
layers is increased to a similar extent in 1/1
(arrows in A and C) and wa2/2 (arrows in B
and D) transgenic papillomas. Note that the
majority of basal cells are also proliferating
in the nonaffected transgenic skin (arrow-
head in A). Hair follicles are absent in the
affected areas. (C and D) Higher magnifica-
tions of the boxed areas shown in (A) and (B).
Arrowheads point to basal cells.
(E and F) TUNEL staining (green) of adjacent
sections to (A) and (B) showing a significantly
higher number of apoptotic cells in the basal
and suprabasal compartments of transgenic
papillomas in the absence of a wild-type
EGFR (arrows in F). Propidium iodide was
used as a nuclear counterstain. The dotted
lines in (E) and (F) delineate the basal mem-
brane.
(G and H) Immunostaining for keratin 1.
Arrows point to differentiated cells which are
significantly increased in number in wa2/2
tumors (H). Impaired differentiation (I) and re-
duced apoptosis (J) in primary keratinocytes
of wa2/1 K5-SOS-F mice. In vitro differentia-
tion of primary keratinocytes was induced by
suspension culture for the indicated times.
Cells suspended in methyl-cellulose were
harvested and air-dried on coverslips and
scored for the following parameters: (I) Differ-
entiation by the number of anucleated cells,
(J) Apoptosis by the number of small cells
with condensed, fragmented nuclei as judged
by DAPI/TUNEL double staining or hematox-
ylin and eosin staining. Symbols in (I) and (J)
correspond to the same genotypes. Data in (I)
and (J) represent the respective percentages
after counting 300 cells from randomly cho-
sen fields. A second independent experiment
gave similar results (data not shown). (Origi-
nal magnifications: A, B 103; C±H 403)
Increased Apoptosis in wa2/2 K5-SOS-F Transgenic (Figure 4F, arrows). Quantification of apoptosis on multi-
ple sections of different tumors revealed a 3-fold in-Papillomas and Primary Keratinocytes
crease in the number of apoptotic cells in wa2/2 papillo-Although wa2/2 or wa2/wa2 transgenic papillomas
mas (145.3 6 13.6) compared to wild-type tumorswere much smaller in size and developed much later
(50.6 6 9.6). To assess the effect of K5-SOS-F expres-(Figures 2A and 2B), histologically they appeared very
sion on terminal differentiation, tumors of both back-similar to the ones observed in a 1/1 or wa2/1 back-
grounds were stained for Keratin 1 (which is normallyground (Figures 4A and 4B). Staining with the prolifera-
limited to the suprabasal layer of the epidermis).tion marker Ki67 showed that the majority of basal cells
Whereas the expression of K1 was almost absent inwere proliferating and that the number of proliferating
1/1 papillomas, a significantly increased number ofcells was increased to a similar extent in 1/1 and wa2/2
differentiated cells were still present in wa2/2 tumors,transgenic papillomas (Figures 4A±4D). In both back-
suggesting that signaling by the wild-type EGFR mightgrounds, the proliferating cells, which are normally con- negatively affect terminal differentiation tumors (Figures
fined to the basal layer, had expanded to the suprabasal 4G and 4H).
compartments (arrows in Figures 4C and 4D). In con- The survival capacity of primary transgenic keratino-
trast, in adjacent nonaffected transgenic skin, Ki67-pos- cytes was followed during differentiation in vitro, which
itive cells were present in the basal layer (Figure 4A, was induced by deprivation of cell anchorage by means
arrowheads). When skin tumor sections were labeled of suspension culture. Consistent with a differentiation
with the TUNEL technique, a significant increase in the defect, the number of anucleated cells was considerably
number of apoptotic cells was detected in the basal lower in wa2/1 K5-SOS-F keratinocytes after 72 hr of
suspension culture compared to cells of all three otherand suprabasal layers of wa2/2 K5-SOS-F papillomas
Cell
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genotypes (Figure 4I). After 72 hr of suspension culture,
a similar number of apoptotic cells was observed in
nontransgenic wa2/1 and wa2/2 control keratinocytes
(Figure 4J). In contrast, K5-SOS-F keratinocytes in the
presence of a wild-type EGFR displayed only half the
number of apoptotic cells compared to transgenic kera-
tinocytes of a hypomorphic EGFR background (Figure
4J). These results indicate that expression of K5-SOS-F
renders basal keratinocytes prone to hyperproliferation,
but that a functional EGFR is required to negatively regu-
late keratinocyte differentiation and to provide a survival
signal for tumor development.
Impaired Akt but Normal ERK Activation in wa2/2
K5-SOS-F Keratinocytes
To exclude the possibility that lack of tumor formation
in a hypomorphic EGFR background was due to reduced
transgene expression or impaired EGFR activation, pri-
mary basal keratinocyte cultures established from wa2/1
and wa2/2 transgenic mice and nontransgenic litter-
mates were analyzed for protein expression. Western
blot analysis using antibodies against SOS1 confirmed
that the levels of SOS-F protein were similar to the levels
of the endogenous SOS protein and comparable in the
wa2/1 and wa2/2 background (Figure 5A). Likewise,
the levels of EGFR protein were not different between
the various genotypes, and EGF stimulation led to phos-
phorylation of the EGFR, although this was slightly re-
duced in a wa2/wa2 background (Figure 5A) (Luetteke
et al., 1994). Activation of Akt-kinase, which positively
regulates a pathway leading to cell survival in epithelial
cells, was significantly reduced in wa2/2 K5-SOS-F ker-
atinocytes (Figure 5A). In contrast, ERK1/2 phosphoryla- Figure 5. Signaling in Primary Keratinocytes and a Cell-Autono-
tion after EGF treatment was comparable and not influ- mous Function for EGFR
enced by the presence of the hypomorphic wa2 EGFR (A) SOS and EGFR expression and Akt and ERK activation in primary
allele (Figure 5A). These results demonstrate that whereas keratinocytes. Keratinocytes of various genotypes were starved for
ERK activation is not affected, Akt phosphorylation is 48 hr in 0.5% serum and stimulated for 5 min with 20 ng/ml EGF.
Protein extracts were separated on an 8% SDS-polyacrylamide gel,impaired in wa2/2 transgenic keratinocytes, thus pro-
transfererred to a membrane and immunoblotted with the indicatedviding a molecular explanation for the survival function
antibodies.of the EGFR.
(B) Quantitative RT-PCR measuring HB-EGF and EGFR transcripts inTo investigate if the presence of K5-SOS-F was lead-
primary keratinocytes and dermal fibroblasts. Cells of the respective
ing to increased expression of EGFR ligands, thereby genotypes were starved for 48 hr in 0.5% serum and stimulated for
activating an autocrine loop, total RNA was extracted 4 hr with 20 ng/ml EGF.
from different keratinocyte cultures. Quantitative RT- (C±E) Histological sections of skin lesions developing from wa2/1
(C), wa2/1 K5-SOS-F (D), and wa2/2 K5-SOS-F (E) keratinocytesPCR analysis revealed that EGF stimulation resulted in
grafted in combination with wa2/2 dermal fibroblasts onto the backan elevation of HB-EGF mRNA transcription and that
of nude mice. Note the big papilloma-like structure of the tumorHB-EGF induction was significantly enhanced by the
derived from wa2/1 K5-SOS-F keratinocytes (D) versus the smallexpression of K5-SOS-F (Figure 5B). The transcription
lesion observed in wa2/2 K5-SOS-F keratinocytes (E). Arrows in
of the EGFR itself was not significantly altered (Figure (E) point to hyperplastic papilloma-like structures. No hyperplasias
5B). These data suggest that an autocrine loop might were detected in the control (C). Arrow in (C) points to the site of
be activated, but since the induction of HB-EGF expres- wound closure in the grafted skin. All the lesions were isolated 7
sion is increased in both wa2/1 and wa2/2 K5-SOS-F weeks after grafting. (Original magnifications: C±E, 53)
keratinocytes, this alone can not account for the differ-
ences in tumor formation observed in vivo. A Cell-Autonomous Requirement for the EGFR
We next investigated whether the lack of skin tumor in Keratinocytes
formation in a wa2/2 background could be attributed To analyze whether the EGFR was required cell-autono-
to differences between wa2/1 versus wa2/2 dermis. mously in transgenic keratinocytes and to demonstrate
For this purpose, primary dermal fibroblasts were iso- that mutant dermis was able to support tumor growth,
lated from mice of all four genotypes. Quantitative RT- grafting experiments were performed with transgenic
PCR analysis did not reveal significant differences in keratinocytes in combination with wa2/2 dermal fibro-
expression levels of HB-EGF and EGFR in all fibroblast blasts. In grafts from wa2/1 K5-SOS-F keratinocytes,
groups, which were not affected by the presence of K5- tumors became apparent after 4 weeks while no tumors
SOS-F, since the latter is not expressed in the dermis could be detected in grafts established with wa2/2 K5-
SOS-F keratinocytes. Within the next 3 weeks, the tumors(Figure 5B).
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derived from wa2/1 K5-SOS-F keratinocytes increased produced by grafting v-ras infected EGFR2/2 keratino-
cytes onto nude mice were smaller than EGFR wild-in size and appeared macroscopically and histologically
type Ras tumors, although no significant increase inas typical papillomas (Figure 5D). After 7 weeks, one of
apoptosis was detected (Dlugosz et al., 1997). It is possi-the grafts from wa2/2 K5-SOS-F keratinocytes ap-
ble that the high expression levels of constitutively ac-peared as a small papillomatous lesion which was .20
tive viral Ras results in maximal stimulation of directtimes smaller than the papillomas derived from wa2/1
downstream targets such as PI3-kinase, which mediatestransgenic keratinocytes. Histological examination of
cell survival via Akt, so that an additional survival inputthe lesion derived from wa2/2 K5-SOS-F keratinocytes
from the EGFR is functionally insignificant. In K5-SOS-Frevealed a hyperplastic epidermis (Figure 5E, arrows),
keratinocytes, Ras, which is the direct target of SOS,whereas no signs of hyperplasia could be detected in
would still be a limiting factor in the signaling cascade,control grafts established with wa2/1 keratinocytes
thus avoiding activation of multiple effector pathways.(Figure 5C). These results indicate that a functional
Therefore, an additional SOS/Ras-independent survivalEGFR is needed in keratinocytes to promote tumor de-
signal originating from the EGFR becomes essential forvelopment in K5-SOS-F mice and that papilloma forma-
tumor development.tion is most likely not influenced by the presence or
The EGFR has been implicated in the regulation ofabsence of a functional EGFR in the dermis.
cell survival in epithelial cells. EGFR activation in kera-
tinocytes can lead to transcription of bcl-XL, a memberDiscussion
of the bcl-2 family of proteins, and human keratinocytes
show increased apoptosis when treated in vitro withK5-SOS-F transgenic mice develop spontaneous skin
blocking EGFR antibodies or EGFR-specific tyrosine ki-
tumors, which resemble the lesions observed in trans- nase inhibitors (Rodeck et al., 1997a, 1997b; Stoll et al.,
genic mice expressing an activated Ras in hair follicles 1998). However, little is known about the signal trans-
(Brown et al., 1998), suggesting that hyperkeratosis may duction pathways linking the EGFR to regulation of cell
result from activation of the Ras signaling pathway by survival. Oncogenic Ras has been shown to regulate
SOS. Epidermal thickening and papilloma formation both pro- and antiapoptotic pathways (Downward,
were also observed in K14-TGFa transgenic mice. How- 1998). Cell survival is mediated by PI3-kinase and Akt
ever, the epidermal hyperplasia of K14-TGFa mice re- whereas the Raf pathway is required for Ras-induced
gressed with time, and terminal differentiation was not apoptosis (Downward, 1998). In wa2/2 keratinocytes,
perturbed (Vassar and Fuchs, 1991). As EGFR expres- ERK1/2 activation, which is directly regulated by Raf, is
sion is unaffected in K14-TGFa mice, it seems that li- not markedly altered even in the presence of K5-SOS-F.
gand-induced EGFR stimulation alone is not capable of In contrast, Akt phosphorylation is reduced in wa2/2
inducing epidermal hyperproliferation and that constitu- K5-SOS-F keratinocytes, indicating that an EGFR-
tive activation of the EGFR or SOS/Ras are required to dependent signal is necessary for maximal Akt activa-
trigger tumor formation (Vassar and Fuchs, 1991). tion. Although it is tempting to speculate that Akt is a
Ras activation has been shown to directly affect termi- mediator of the survival function of the EGFR, it can not
nal differentiation of keratinocytes. Retroviral infection be excluded that there are additional molecular targets
of v-ras in wild-type keratinocytes results in suppression of EGFR-dependent survival signaling. Recently, it was
of K1 and K10 expression and protein kinase C (PKC) shown in the fruit fly Drosophila melanogaster that EGFR
activity, which is thought to promote keratinocyte differ- signaling via the Ras/ERK pathway promotes cell sur-
entiation (Denning et al., 1993; Dlugosz et al., 1994). In vival by downregulating the expression of the proapo-
contrast, v-ras infected EGFR2/2 keratinocytes do not ptotic gene hid (Bergmann et al., 1998; Kurada and
downregulate K1 and K10 and maintain high PKC activ- White, 1998), suggesting that two independent path-
ity, indicating that EGFR might negatively regulate kera- ways, one by Ras/ERK and one by the EGFR, have to
tinocyte terminal differentiation (Denning et al., 1996; converge for efficient repression of such proapoptotic
Dlugosz et al., 1997). A higher number of K1/10 positive signals. The survival function of the EGFR is not only
keratinocytes was detected in wa2/2 K5-SOS-F kera- restricted to SOS-F-transformed keratinocytes, but can
tinocytes and papillomas, supporting the hypothesis also be demonstrated in mesenchymal cells, since
that impaired EGFR signaling promotes keratinocyte dif- EGFR2/2 fibroblasts and NIH 3T3 cells expressing a
ferentiation. The premature differentiation might in part dominant-negative EGFR are also resistant to trans-
explain why papilloma development is severely impaired formation by oncogenic forms of hSOS and Ras. Inter-
in an EGFR null or wa2/wa2 background. In K5-SOS-F estingly, expression of the antiapoptotic gene bcl-2 in
papillomas as well as in primary keratinocytes, the num- SOS-F-transfected EGFR2/2 fibroblasts restores trans-
ber of proliferating cells was increased to the same ex- formation and the capability to form tumors in nude mice.
tent in wild-type and wa2/wa2 background. Similarly, the Overexpression of members of the Ras signaling path-
EGFR does not seem to be required in v-ras mediated way have been shown to induce the secretion of EGFR
keratinocyte proliferation, since the proliferation capac- ligands and therefore activate an autocrine loop contrib-
ity of v-ras infected EGFR2/2 or 1/1 keratinocytes was uting to cellular transformation (McCarthy et al., 1995;
comparable (Dlugosz et al., 1997). These results suggest Gangarosa et al., 1997). An increase in the expression
that a functional EGFR is not required for proliferation of of the EGFR ligand HB-EGF was observed in transgenic
SOS-F or Ras transformed cells, but that EGFR signaling keratinocytes in both wa2/1 and wa2/2 backgrounds.
might negatively affect terminal differentiation of basal Therefore, the increased HB-EGF expression in the pres-
keratinocytes. ence of K5-SOS-F might establish an autocrine stimula-
In the absence of a wild-type EGFR, K5-SOS-F papillo- tion of the EGFR that contributes to tumor development.
mas and keratinocytes show increased apoptosis, sug- However, since the HB-EGF gets activated in both wa2/1
gesting that the EGFR also provides a survival signal for and wa2/2 transgenic keratinocytes, this alone is un-
likely to account for the differences in tumor formation.tumor cells. It was shown that squamous cell papillomas
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the basal compartment prematurely, since the absence
of the EGFR favors terminal differentiation. Moreover,
the survival signal activated by the EGFR (possibly by
Akt), is missing, and due to these conflicting signals,
keratinocytes would be committed to apoptose (Kauff-
mann-Zeh et al., 1997). As a consequence, no tumors
develop in the absence of a functional EGFR (Figure
6B). Since in vitro keratinocytes are grown on plastic
substrates, this might also explain why undifferentiated
SOS transgenic keratinocytes in a wa2/wa2 background
do not show increased apoptosis unless they are in-
duced to differentiate by placing them in suspension.
A similar scenario could be true for other human tu-
mors, which carry activating mutations in components
of the Ras signaling pathway. The tumor cells would
be prone to hyperproliferation, and the EGFR (or other
growth factor receptors) may additionally provide sur-
vival signals. The EGFR itself is frequently amplified,
overexpressed, or rearranged in human squamous cell
carcinomas and glioblastomas (Libermann et al., 1985;
Derynck, 1992). Thus far, it has never been clarified
whether the EGFR simply provides a proliferation advan-
tage to tumor cells or if other cellular processes are
altered. Since EGFR amplifications and rearrangements
often occur at later stages of tumor development, one
would exclude that the only function of the EGFR is to
provide a proliferation advantage. It is likely that the
EGFR triggers multiple downstream survival pathways,
rendering tumor cells more aggressive and resistant to
chemotherapeutic drugs, which usually induce apopto-
Figure 6. EGFRÐA Potent Survival Signal for Tumor Cells? sis by activating only one of the apoptotic programs
Consequence of SOS-F expression in EGFR wild-type (wt) and mu- (Nagane et al., 1998). Therefore, the conventional che-
tant (wa2) epidermis. Keratinocyte survival, proliferation, and differ- motherapy combined with EGFR-specific inhibitors
entiation are tightly regulated processes during skin development. might prove to be more successful in antitumor ther-
Whereas Ras induction is essential for keratinocyte proliferation,
apies.EGFR signaling in basal keratinocytes activates an antiapoptotic
pathway, possibly via Akt, and inhibits keratinocyte differentiation
in a SOS/Ras-dependent and/or -independent manner. Experimental Procedures
(A) Expression of a dominant SOS-F activates Ras and therefore
leads to increased proliferation and reduced differentiation of kera- Generation of K5-SOS-F Transgenic Mice and Establishment
tinocytes. In addition, the wild-type EGFR acts as a potent survival of Transgenic Lines in Different EGFR Backgrounds
signal leading to skin tumor development. A constitutively active, HA-tagged form of hSOS (SOS-F) (Aronheim
(B) In the presence of a hypomorphic EGFR, the survival pathway et al., 1994) was excised from the plasmid vector as a HindIII frag-
downstream of the EGFR is not sufficiently activated and, as a ment, blunt ended, and inserted into a Sna BI site downstream of
consequence, tumors can not develop. the K5 regulatory region (Murillas et al., 1995). The K5-SOS-F frag-
ment was excised from the plasmid vector after digestion with the
restriction enzymes SalI and NotI. Transgenic mice were generatedReduced tumor development in an EGFR hypomorphic
by pronuclear injection of the purified K5-SOS-F DNA fragment intobackground is most likely not caused by the lack of a
fertilized oocytes from (C57BL/6 3 CBA) F1 mice. Founders were
wild-type receptor in the dermis, since wa2/1 K5-SOS-F identified by Southern blot analysis (data not shown)
keratinocytes grafted in combination with wa2/2 dermal Founder 892A6* was first backcrossed to EGFR1/2 mice of
fibroblasts onto nude mice form papillomas that are C57BL/6 background and the resulting EGFR1/2 K5-SOS-F trans-
similar to the ones developing in a wild-type EGFR back- genics were further backcrossed to EGFRwa2/wa2 mice of LVC
ground. background (MRC-Chilton) to obtain wa2/1 and wa2/2 mice harbor-
ing the transgene. To monitor tumor incidence in the various EGFR
backgrounds, offspring born from intercrosses between wa2/1 K5-EGFRÐA Potent Survival Signal for Tumor Cells
SOS-F 3 wa2/wa2 and wa2/2 K5-SOS-F 3 wa2/wa2 were kept andEGFR signaling appears to have two functions during
monitored over a year for the appearance of papillomas.skin development: it provides a survival signal by acti-
vating an antiapoptotic pathway and inhibits keratino-
Histology, Immunohistochemistry, and TUNEL Stainingcyte differentiation, thereby keeping basal cells in the
Mouse tissues were fixed overnight in 4% paraformaldehyde, dehy-proliferative compartment attached to the basal mem-
drated, and embedded in paraffin. 5 mm sections were stained eitherbrane. K5-SOS-F keratinocytes are prone to hyperprolif-
with hematoxylin and eosin or processed further. Immunohisto-eration independent of whether a wild-type or mutant
chemical staining for Ki67 (Novocastra, NCL-Ki67p, 1:1000) was
EGFR is present. In a wild-type EGFR background, hy- performed using the ABC Staining Kit (Vector Laboratories) ac-
perproliferation induced by SOS-F together with the sur- cording to the manufacturer's recommendations. Immunostainings
vival signal provided by the EGFR will lead to skin tumor of mouse skins with keratins were performed as described (Carroll
development (Figure 6A). In a wa2/2 transgenic back- et al., 1995).
ground, SOS-F expression will still lead to hyperprolifer- TUNEL staining was performed using the in situ cell death detec-
tion kit II (Boehringer Mannheim).ation; however, keratinocytes will be induced to leave
EGFR-Dependent Cell Survival in Skin Tumors
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Isolation and Culture of Mouse Keratinocytes vectors 24 hr later. For the focus assay, cells were cultured in the
same dishes without selection for 2 weeks. Cells were fixed andand Dermal Fibroblasts
Mouse keratinocytes were isolated as previously described and stained with 0.2% methylene blue (v/v in methanol). The number of
macroscopically visible foci was estimated by visual examination.cultured onto vitrogen-fibronectin coated dishes in low calcium
MEM (Sigma M8167) medium containing 8% chelated FCS (Carroll For the tumorigenicity assay, the transfected or infected cells
were selected with G418, puromycin, or hygromycin for 1 week untilet al., 1995). Keratinocytes were induced to undergo terminal differ-
entiation by suspension culture and recovered at the indicated time all noninfected/transfected cells had died. 1 3 106 resistant cells
were subcutaneously injected into 3- to 5-week old anaesthetizedpoints as previously described (Gandarillas et al., 1999).
For the isolation of dermal fibroblasts, mouse ears ears were split nude mice and the appearance of tumors was monitored.
into dorsal and ventral side and placed in 1% trypsin for 45 min at
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